Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis
Clinical trial NCT01201356 · COMPLETED
Trial details
- NCT number
- NCT01201356
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-13
- Primary completion
- 2018-10-19
- Enrollment
- 4125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.